Creating new compounds for cancer treatment
SYNTHESIS OF UP TO TEN SAMPLE COMPOUNDS PER YEAR (Option Yr 3)
This study is working on creating new medicines to help treat cancer, with the hope that these new drugs will offer better treatment options for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Alchem Laboratories Corporation NIH-funded |
| Lab location | 1 site (Alachua, United States) |
| Project ID | NIH-11167407 on NIH RePORTER |
What this research studies
This research focuses on synthesizing new therapeutic agents specifically designed for cancer treatment. The Developmental Therapeutics Program aims to acquire and produce gram quantities of various compounds that are currently in human clinical development. By engaging contractors, the program seeks to create specific compounds that may enhance cancer therapy options. Patients may benefit from the development of these new drugs as they could lead to more effective treatment options for various types of cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with cancer who may benefit from novel therapeutic agents.
Not a fit: Patients who are not currently undergoing cancer treatment or those with non-malignant conditions may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide patients with access to new and potentially more effective cancer therapies.
How similar studies have performed: Previous research in drug synthesis for cancer treatment has shown success, indicating that this approach is promising and not entirely novel.
Where this research is happening
Alachua, United States
- Alchem Laboratories Corporation — Alachua, United States (Active)
Researchers
- Principal investigator: Talton, James — Alchem Laboratories Corporation
- Study coordinator: Talton, James
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.